Custom service
Biotinylated pMHC Monomer Production
Produce biotinylated peptide–mhc monomers as the raw material for tetramers
The service is built around BirA-acceptor-peptide construct design. Depending on the molecule we may move to in-vitro biotinylation or SEC polishing of monomer to improve stability, loading or yield, and every batch is released with biotinylated pMHC monomer with biotinylation ratio.
Because Biotinylated pMHC Monomer Production projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.
Downstream tetramer and dextramer assembly
SPR and BLI binding studies
Monomers without a defined target peptide
Alleles or peptides with no published refolding precedent and no feasibility budget
Each tetramer lot is tested functionally, not just biochemically: a known antigen-specific T cell line or clone is stained, and the lot is released only if the staining profile meets the agreed specification. Allele and peptide identity are confirmed by MS.
Service Highlights
- BirA-acceptor-peptide construct design as the default route, with in-vitro biotinylation held as a proven fallback
- SEC polishing of monomer worked into the design where the application requires it
- Refolding yield and monomer integrity confirmed by SEC before tetramerization
- Analytical confirmation of every intermediate before the final release
- Fluorescent labels chosen and titrated so staining signal stays in the linear range
- Biotinylated pMHC monomer with biotinylation ratio delivered with a complete conjugation or synthesis certificate
How the work runs
Construct design
Allele, peptide and biotinylation acceptor peptide are confirmed, and the expression construct strategy is agreed.
Inclusion body preparation
Heavy chain and β2-microglobulin are expressed and purified as inclusion bodies.
Refolding
Chain, β2M and peptide are folded together under redox-buffered conditions optimized for the allele.
Biotinylation & purification
Monomer is BirA-biotinylated and polished by SEC-HPLC to remove aggregates.
Tetramerization
Fluorescent streptavidin is titrated in to form stable tetramers with controlled label ratio.
Functional release
Biotinylated pMHC monomer with biotinylation ratio is released after flow-cytometry binding confirmation against the specification.
Specifications & timeline
- Turnaround
- 4–6 weeks
- Typical scale
- 50 µg – 1 mg tetramer per construct
- Chemistry options
- BirA-acceptor-peptide construct design; in-vitro biotinylation; SEC polishing of monomer
- Deliverable
- Biotinylated pMHC monomer with biotinylation ratio
- QC package
- SEC-HPLC monomer integrity, biotinylation ratio, flow-cytometry binding test
- Shipping
- Dry ice, aliquoted to avoid freeze-thaw
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.